|
Osteoarthritis
Citations 21-28 of 28 total displayed.
|
Past content
(since Jun 2000):
|
- Editor's Correspondence
What Now About Acetaminophen?—Reply
- John P. Case; Algis Baliunas; Joel A. Block
Arch Intern Med 2003; 163: 1863.
[Extract]
[Full text]
[PDF]
- Original Investigations
Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee Osteoarthritis: A Comprehensive Meta-analysis
- Florent Richy; Olivier Bruyere; Olivier Ethgen; Michel Cucherat; Yves Henrotin; Jean-Yves Reginster
Arch Intern Med 2003; 163: 1514-1522.
[Abstract]
[Full text]
[PDF]
- Original Investigations
The Effect of Glucosamine-Chondroitin Supplementation on Glycosylated Hemoglobin Levels in Patients With Type 2 Diabetes Mellitus: A Placebo-Controlled, Double-blinded, Randomized Clinical Trial
- Daren A. Scroggie; Allison Albright; Mark D. Harris
Arch Intern Med 2003; 163: 1587-1590.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Lack of Efficacy of Acetaminophen in Treating Symptomatic Knee Osteoarthritis: A Randomized, Double-blind, Placebo-Controlled Comparison Trial With Diclofenac Sodium
- John P. Case; Algis J. Baliunas; Joel A. Block
Arch Intern Med 2003; 163: 169-178.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Physical Exercise and the Prevention of Disability in Activities of Daily Living in Older Persons With Osteoarthritis
- Brenda W. J. H. Penninx; Stephen P. Messier; W. Jack Rejeski; Jeff D. Williamson; Mauro DiBari; Chiara Cavazzini; William B. Applegate; Marco Pahor
Arch Intern Med 2001; 161: 2309-2316.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Safety and Efficacy of Meloxicam in the Treatment of Osteoarthritis: A 12-Week, Double-blind, Multiple-Dose, Placebo-Controlled Trial
- David Yocum; Roy Fleischmann; Paul Dalgin; Jacques Caldwell; David Hall; Paul Roszko; for the Meloxicam Osteoarthritis Investigators
Arch Intern Med 2000; 160: 2947-2954.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis
- Douglas J. Watson; Sean E. Harper; Peng-Liang Zhao; Hui Quan; James A. Bolognese; Thomas J. Simon
Arch Intern Med 2000; 160: 2998-3003.
[Abstract]
[Full text]
[PDF]
- Original Investigations
A Randomized Trial of the Efficacy and Tolerability of the COX-2 Inhibitor Rofecoxib vs Ibuprofen in Patients With Osteoarthritis
- Ric Day; Briggs Morrison; Armando Luza; Oswaldo Castaneda; Alberto Strusberg; Menachem Nahir; Knut Bjorn Helgetveit; Barbara Kress; Brian Daniels; James Bolognese; Dave Krupa; Beth Seidenberg; Elliot Ehrich; for the Rofecoxib/Ibuprofen Comparator Study Group
Arch Intern Med 2000; 160: 1781-1787.
[Abstract]
[Full text]
[PDF]
|
|
